student working in the labNationally Recognized Research Centers of Excellence

The Boonshoft School of Medicine houses several research centers of excellence that are nationally recognized, as well as a University System of Ohio Center of Excellence. Currently, the medical school employs 132 research faculty and staff. Over the past five years, the Boonshoft School of Medicine received a total of $110,402,178 in research and sponsored program funding. Medical students have ample opportunities to participate in this vibrant research community, and many present their work at the school’s annual Medical Student Research Symposium.

Designated as a University System of Ohio Center of Excellence,  the Wright State University & Premier Health Neuroscience Institute represents a groundbreaking public-private partnership that unites the Dayton region’s most advanced biomedical research institution with the clinical resources of its largest hospital system. The research component of the institute is located in a cutting-edge Neuroscience Engineering Collaboration Building that opened in 2015 on the WSU campus, with facilities dedicated to patient care and clinical research located at Miami Valley Hospital. In addition, the partners created a new clinical Department of Neurology and affiliated Neurology Residency Program within the Boonshoft School of Medicine. The institute already has a core cadre of NIH-funded neuroscientists, including a team of Wright State researchers awarded a prestigious Program Project Grant of nearly $5 million in 2007 and renewed in 2012 by the National Institute of Neurological Disorders and Stroke.

The school’s key facilities also include the Matthew O. Diggs III Laboratory for Life Science Research completed in 2007, which was the first university research laboratory in Ohio to be awarded Leadership in Energy and Environmental Design-New Construction (LEED-NC) Gold status by the U.S. Green Building Council. In addition, the school is home to a fully accredited laboratory animal resources facility, a Biosafety Level 3 Facility, a chemical surety facility (XCSM), a genomics core facility with advanced gene array systems, proteomics analysis and nuclear magnetic resonance laboratories with multiple mass spectrometers and related equipment and a confocal and electron microscopy imaging core facility.

Another collaboration between the Boonshoft School of Medicine and Premier Health led to the creation of the Clinical Trials Research Alliance (CTRA) to increase medical research opportunities for physicians and clinicians at the medical school and Premier hospitals. Since its inception in 2012, CTRA has successfully completed more than 50 trials for such leading sponsors and CROs as Abbott, AbbVie, Bayer, Boehringer Ingelheim, Genentech, Gilead Sciences, Inc., Quintiles, Pfizer, PPD, PRA, Parexel and Sanofi..

A Broad Range of Investigation

The Center for Interventions, Treatment and Addictions Research (CITAR) advances the production, dissemination and utilization of scientific knowledge and professional technology regarding the epidemiology, consequences, prevention and treatment of substance abuse. It conducts wide-ranging research through programs such as the Dayton Area Drug Survey (DADS) and the NIDA National Early Warning System Network (iN3). In 2010, Public Health–Dayton & Montgomery County awarded CITAR a contract, funded by a grant from the Ohio Department of Health, to investigate the high rate of unintentional prescription drug overdoses in Montgomery County through the Unintentional Drug Overdose Poisoning Project;.

Wright State’s Center for Genomics Research (CGR) provides state-of-the-art technical assistance and facilities for both basic and clinical science projects in the areas of gene expression, flow cytometry and genotyping. CGR supports Wright State researchers, as well as industry partners and collaborations with the 711th Human Performance Wing at the Air Force Research Laboratory at Wright-Patterson Air Force Base.

The Proteome Analysis Laboratory (PAL) is a Wright State University facility for the analysis of protein/peptide expression in cells, tissues and body fluids. Proteomics is the study of the intricate structure and function of thousands of proteins in cells and tissues. Diseases result when proteins, which are encoded by our genes, are defective or malfunctioning. Like the study of genetic defects, the in-depth study of proteins will produce medical advances. Current investigations involve the proteome and genome of the hypothalamic, pituitary, adrenal, pancreatic-axis (HPAP-Axis) under normal, disease or chemically challenged conditions. One goal of the PAL is to provide high-quality proteomic services to the faculty and staff of Wright State University, to researchers outside Wright State University and to provide support for intramural and extramural grants.

Through a collaborative partnership with Premier Health and the Dayton VA Medical Center, the Boonshoft School of Medicine established a Department of Geriatrics to enhance geriatrics education for the next generation of physicians and expand geriatric research. Researchers are studying macular degeneration, a form of age-related vision loss that most often strikes individuals over 65. Other elder issues — such as sleep disorders, Alzheimer's disease and bone thinning — are also under study.

Research News

Additional dates added for Wright State research study on bipolar disorder and schizophrenia

This part of the study seeks African-Americans age 18 or older who do not have a diagnosis of bipolar disorder or schizophrenia.
Continue reading in Wright State Newsroom

Wright State University awarded prestigious Multidisciplinary University Research Initiative from the Office of Naval Research

The Wright State project is focused on discovering epigenetic biomarkers that identify individuals who could benefit from high-intensity training.
Continue reading in Wright State Newsroom
Robert carlson

Overdose death rate continues to rise in Montgomery County

“We have seen a 26 percent increase in the use of illicit Fentanyl in people who have died of drug overdoses," said CITAR director Robert Carlson, Ph.D.
Continue reading
Last edited on 09/23/2016.